We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Ensign Expands Footprint With Buyout of Eight Healthcare Facilities
Read MoreHide Full Article
The Ensign Group, Inc. (ENSG - Free Report) recently announced that it has agreed to buy eight healthcare facilities in Alaska, Washington, Oregon, and California, subject to approvals and closing conditions. These operations are being acquired from Providence Home and Community Care, and the real estate assets are being purchased by Standard Bearer Healthcare REIT, Inc., Ensign’s real estate subsidiary.
This move will allow Ensign to enter new markets in Alaska and Oregon, enhancing its geographic reach and diversifying its portfolio. Six facilities will be managed by Ensign-affiliated operating companies, and two will be leased to third-party operators under long-term agreements. This transaction is expected to be effective in the next few months.
The acquisition deals have increased Ensign's portfolio to encompass 330 healthcare operations in 16 states. Of these, 32 also have senior living operations. The company, along with its subsidiaries like Standard Bearer, now owns 134 real estate properties.
The acquisitions are expected to provide Ensign with high-quality assets and new opportunities to establish clusters in emerging markets. These clusters enable operational efficiencies and improved resource allocation, benefiting patients and caregivers.
ENSG boasts a strong inorganic growth story. The company remains committed to acquiring real estate and leasing both successful and struggling skilled nursing, senior living and other healthcare-related operations. As the number of facilities rises, revenues from skilled services are expected to increase, supported by higher occupancy rates and patient days, indicating robust profit growth. ENSG’s EPS is forecasted to be between $5.46 and $5.52 for 2024, the midpoint of which suggests more than 15.1% growth from the 2023 figure of $4.77.
Ensign’s Price Performance
Shares of Ensign have risen 10.9% in the past three months compared with the industry’s 2.7% growth.
Image Source: Zacks Investment Research
ENSG’s Zacks Rank & Other Key Picks
The company currently carries a Zacks Rank #2 (Buy).
The Zacks Consensus Estimate for Doximity’s 2024 bottom line suggests 20% year-over-year growth. DOCS witnessed eight upward estimate revisions over the past 60 days against no movement in the opposite direction. It beat earnings estimates in each of the last four quarters, with the average surprise being 22.1%.
The Zacks Consensus Estimate for CareDx’s 2024 earnings is pegged at 43 cents per share, which indicates 167.2% growth from a year ago. In the past month, CDNA witnessed one upward estimate revision against none in the opposite direction.
The Zacks Consensus Estimate for Abbott Laboratories 2024 full-year earnings implies a 5.2% increase from the year-ago reported figure. ABT beat earnings estimates in three of the last four quarters, missing once, with an average surprise of 1.6%. The consensus mark for its current-year revenues is pegged at $42 billion, which indicates a 4.7% year-over-year increase.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Shutterstock
Ensign Expands Footprint With Buyout of Eight Healthcare Facilities
The Ensign Group, Inc. (ENSG - Free Report) recently announced that it has agreed to buy eight healthcare facilities in Alaska, Washington, Oregon, and California, subject to approvals and closing conditions. These operations are being acquired from Providence Home and Community Care, and the real estate assets are being purchased by Standard Bearer Healthcare REIT, Inc., Ensign’s real estate subsidiary.
This move will allow Ensign to enter new markets in Alaska and Oregon, enhancing its geographic reach and diversifying its portfolio. Six facilities will be managed by Ensign-affiliated operating companies, and two will be leased to third-party operators under long-term agreements. This transaction is expected to be effective in the next few months.
The acquisition deals have increased Ensign's portfolio to encompass 330 healthcare operations in 16 states. Of these, 32 also have senior living operations. The company, along with its subsidiaries like Standard Bearer, now owns 134 real estate properties.
The acquisitions are expected to provide Ensign with high-quality assets and new opportunities to establish clusters in emerging markets. These clusters enable operational efficiencies and improved resource allocation, benefiting patients and caregivers.
ENSG boasts a strong inorganic growth story. The company remains committed to acquiring real estate and leasing both successful and struggling skilled nursing, senior living and other healthcare-related operations. As the number of facilities rises, revenues from skilled services are expected to increase, supported by higher occupancy rates and patient days, indicating robust profit growth. ENSG’s EPS is forecasted to be between $5.46 and $5.52 for 2024, the midpoint of which suggests more than 15.1% growth from the 2023 figure of $4.77.
Ensign’s Price Performance
Shares of Ensign have risen 10.9% in the past three months compared with the industry’s 2.7% growth.
Image Source: Zacks Investment Research
ENSG’s Zacks Rank & Other Key Picks
The company currently carries a Zacks Rank #2 (Buy).
Investors can look at some other top-ranked stocks in the broader Medical space, like Doximity, Inc. (DOCS - Free Report) , CareDx, Inc (CDNA - Free Report) and Abbott Laboratories (ABT - Free Report) . While Doximity currently sports a Zacks Rank #1 (Strong Buy), CareDx and Abbott Laboratories carry a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Doximity’s 2024 bottom line suggests 20% year-over-year growth. DOCS witnessed eight upward estimate revisions over the past 60 days against no movement in the opposite direction. It beat earnings estimates in each of the last four quarters, with the average surprise being 22.1%.
The Zacks Consensus Estimate for CareDx’s 2024 earnings is pegged at 43 cents per share, which indicates 167.2% growth from a year ago. In the past month, CDNA witnessed one upward estimate revision against none in the opposite direction.
The Zacks Consensus Estimate for Abbott Laboratories 2024 full-year earnings implies a 5.2% increase from the year-ago reported figure. ABT beat earnings estimates in three of the last four quarters, missing once, with an average surprise of 1.6%. The consensus mark for its current-year revenues is pegged at $42 billion, which indicates a 4.7% year-over-year increase.